-+ 0.00%
-+ 0.00%
-+ 0.00%

TScan Therapeutics says CFO Jason Amello steps down in reorganization

PUBT·09/30/2026 21:01:04
Listen to the news
TScan Therapeutics says CFO Jason Amello steps down in reorganization
  • TScan Therapeutics disclosed planned executive departures tied to a strategic reorganization.
  • Jason A. Amello will step down as chief financial officer, with employment ending by Nov. 1, 2026.
  • Chrystal Louis, M.D., MPH will step down as chief medical officer, with employment ending by Nov. 1, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TScan Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-409199), on September 30, 2026, and is solely responsible for the information contained therein.